Iberogast® for Healthcare Professionals

Frequently Asked Questions

Find out more about the most frequently asked questions on Iberogast.

  • Iberogast is registered as an OTC medicine for the treatment of gastric and abdominal discomfort associated with motility-conditioned gastrointestinal disturbances such as Functional Dyspepsia and Irritable Bowel Syndrome. Symptoms include stomach pain, abdominal cramps, bloating, flatulence, heartburn, nausea, fullness, diarrhoea and constipation.

  • Iberogast is recommended to be taken before or with meals up to 3 times daily. May be mixed with warm or cold water, or drink of choice.

                                        Single dose
    Adults and children over 12 years 20 drops (1.0mL)
    Children 6 to 12 years 15 drops (0.75mL)
    Children 3 to 6 years 10 drops (0.5mL)
    Children 3 months to 3 years 8 drops (0.4mL)
    Children under 3 months 6 drops (0.3mL)
  • Iberogast is a unique combination of 9 specific plant extracts. Its efficacy has been verified by robust scientific research. In numerous clinical trials Iberogast has been proven to be highly effective, well-tolerated and fast-acting.

  • Many consumers report rapid improvement of functional digestive symptoms after intake, most often after 15 to 30 minutes.

  • Although there has been no evidence or clinical data for concern, Iberogast should only be taken during pregnancy and breastfeeding after consultation with a physician.

  • Yes, Iberogast contains alcohol, which plays an important role in the herbal extraction process. However, the dosage used is only 1mL or less each time and thus the amount of alcohol actually consumed is very small. One single dose for adults (20 drops of Iberogast) contains only 0.24g of alcohol, which is less than the alcohol content in one average 200ml glass of apple juice. Nonetheless, individuals with a history of alcoholism should refrain from taking Iberogast, unless under medical supervision. Supervision is also advised for patients with severe liver or kidney impairment.

  • Iberogast is very well tolerated. Clinical trials showed comparable adverse event profiles compared to placebo. Rare hypersensitivity reactions such as skin rash, itching or difficulty breathing have been reported.

  • There are no known interactions with other substances or medications.

  • Based on the available clinical and experience data, there is no recommendation to stop taking Iberogast before surgery. However, it is important to discuss this with an anesthetist and/or surgeon.

  • Yes, Iberogast is suitable for long-term use. The length of use depends on the type, severity, and course of the disease.

  • No, Iberogast does not contain gluten.

  • No, Iberogast does not contain lactose.

  • If used as intended and at the recommended dosage, no impairment of the ability to actively drive vehicles or operate machines is anticipated.